天大药业（珠海）有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
14
NMPA:14
Drug Approvals
Ambroxol Hydrochloride and Clenbuterol Hydrochloride Oral Solution
- Product Name
- 氨溴特罗口服溶液
- Approval Number
- 国药准字H20253835
- Approval Date
- Apr 8, 2025
NMPA
Metformin Hydrochloride and Empagliflozin Tablets（I）
- Product Name
- 二甲双胍恩格列净片(Ⅰ)
- Approval Number
- 国药准字H20249230
- Approval Date
- Oct 29, 2024
NMPA
Ribavirin Effervescent Granules
- Product Name
- 利巴韦林泡腾颗粒
- Approval Number
- 国药准字H20058840
- Approval Date
- Mar 11, 2020
NMPA
Ribavirin Effervescent Granules
- Product Name
- 利巴韦林泡腾颗粒
- Approval Number
- 国药准字H20058839
- Approval Date
- Mar 10, 2020
NMPA
Ambroxol Hydrochloride Syrup
- Product Name
- 盐酸氨溴索糖浆
- Approval Number
- 国药准字H20058517
- Approval Date
- Mar 3, 2020
NMPA
Dextromethorphan Hydrobromide,Chlorphenamine Maleate and Pseudoephedrine Hydrochloride Oral Solution
- Product Name
- 美敏伪麻口服溶液
- Approval Number
- 国药准字H20045779
- Approval Date
- Jan 13, 2020
NMPA
- Prev
- 1
- 2
- Next
Clinical Trials
No trials found
News
No news found